AnaptysBio Historical Income Statement
| ANAB Stock | USD 19.27 0.09 0.47% |
Historical analysis of AnaptysBio income statement accounts such as Interest Expense of 19 M, Selling General Administrative of 44 M or Total Revenue of 24.4 M can show how well AnaptysBio performed in making a profits. Evaluating AnaptysBio income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of AnaptysBio's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining AnaptysBio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether AnaptysBio is a good buy for the upcoming year.
AnaptysBio |
About AnaptysBio Income Statement Analysis
AnaptysBio Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to AnaptysBio shareholders. The income statement also shows AnaptysBio investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
AnaptysBio Income Statement Chart
AnaptysBio Income Statement is one of the three primary financial statements used for reporting AnaptysBio's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of AnaptysBio revenue and expense. AnaptysBio Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, AnaptysBio's Depreciation And Amortization is projected to increase significantly based on the last few years of reporting. The current year's Interest Expense is expected to grow to about 19 M, whereas Operating Income is projected to grow to (156.2 M). Add Fundamental
Total Revenue
Total revenue comprises all receipts AnaptysBio generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of AnaptysBio. It is also known as AnaptysBio overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from AnaptysBio's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into AnaptysBio current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AnaptysBio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For information on how to trade AnaptysBio Stock refer to our How to Trade AnaptysBio Stock guide.At present, AnaptysBio's Depreciation And Amortization is projected to increase significantly based on the last few years of reporting. The current year's Interest Expense is expected to grow to about 19 M, whereas Operating Income is projected to grow to (156.2 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 1.5M | 21.1M | 18.1M | 19.0M | Depreciation And Amortization | 468K | 7.6M | 2.4M | 2.8M |
AnaptysBio income statement Correlations
Click cells to compare fundamentals
AnaptysBio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
AnaptysBio income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 11.0M | 4.5M | 468K | 7.6M | 2.4M | 2.8M | |
| Interest Expense | 1.0M | 4.0M | 1.5M | 21.1M | 18.1M | 19.0M | |
| Selling General Administrative | 16.1M | 18.9M | 21.5M | 36.6M | 41.9M | 44.0M | |
| Total Revenue | 8M | 75M | 63.2M | 10.3M | 17.2M | 24.4M | |
| Gross Profit | (91.3M) | (5.0M) | (35.3M) | 8.0M | 14.8M | 15.5M | |
| Other Operating Expenses | 115.4M | 98.9M | 120.0M | 125.4M | 174.2M | 182.9M | |
| Operating Income | (107.4M) | (23.9M) | (56.8M) | (115.2M) | (164.4M) | (156.2M) | |
| Ebit | (107.4M) | (23.9M) | (56.8M) | (115.2M) | (138.2M) | (131.3M) | |
| Research Development | 99.3M | 80.0M | 98.5M | 88.8M | 132.3M | 138.9M | |
| Ebitda | (96.4M) | (19.4M) | (56.3M) | (107.6M) | (135.8M) | (129.0M) | |
| Total Operating Expenses | 115.4M | 98.9M | 120.0M | 125.4M | 174.2M | 182.9M | |
| Income Before Tax | (97.5M) | (19.9M) | (57.8M) | (128.7M) | (163.6M) | (155.4M) | |
| Total Other Income Expense Net | 9.9M | 3.9M | (982K) | (13.5M) | (7.3M) | (7.0M) | |
| Net Income | (97.3M) | (19.9M) | (57.2M) | (128.7M) | (163.6M) | (155.4M) | |
| Income Tax Expense | (152K) | (11K) | (603K) | 24K | (4K) | (3.8K) | |
| Net Income From Continuing Ops | (97.3M) | (19.9M) | (57.8M) | (128.7M) | (147.8M) | (140.4M) | |
| Cost Of Revenue | 99.3M | 80.0M | 98.5M | 2.3M | 2.4M | 2.3M | |
| Net Income Applicable To Common Shares | (97.3M) | (19.9M) | (57.8M) | (128.7M) | (115.9M) | (110.1M) | |
| Interest Income | 11.0M | 4.0M | 431K | 7.6M | 17.8M | 18.7M | |
| Net Interest Income | 9.9M | 4.0M | (1.0M) | (13.6M) | 456K | 420.4K | |
| Reconciled Depreciation | 514K | 559K | 2.1M | 2.3M | 2.4M | 1.3M | |
| Non Operating Income Net Other | 11.5M | 3.6M | (1.4M) | (18.4M) | (16.5M) | (15.7M) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards AnaptysBio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, AnaptysBio's short interest history, or implied volatility extrapolated from AnaptysBio options trading.
Pair Trading with AnaptysBio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AnaptysBio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AnaptysBio will appreciate offsetting losses from the drop in the long position's value.Moving against AnaptysBio Stock
| 0.79 | ACB | Aurora Cannabis Trending | PairCorr |
| 0.79 | CGC | Canopy Growth Corp Trending | PairCorr |
| 0.67 | XFOR | X4 Pharmaceuticals Buyout Trend | PairCorr |
| 0.43 | ELYM | Eliem Therapeutics | PairCorr |
The ability to find closely correlated positions to AnaptysBio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AnaptysBio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AnaptysBio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AnaptysBio to buy it.
The correlation of AnaptysBio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AnaptysBio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AnaptysBio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AnaptysBio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AnaptysBio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For information on how to trade AnaptysBio Stock refer to our How to Trade AnaptysBio Stock guide.Note that the AnaptysBio information on this page should be used as a complementary analysis to other AnaptysBio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for AnaptysBio Stock analysis
When running AnaptysBio's price analysis, check to measure AnaptysBio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AnaptysBio is operating at the current time. Most of AnaptysBio's value examination focuses on studying past and present price action to predict the probability of AnaptysBio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AnaptysBio's price. Additionally, you may evaluate how the addition of AnaptysBio to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities |
Is AnaptysBio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AnaptysBio. If investors know AnaptysBio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AnaptysBio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.08) | Revenue Per Share 0.637 | Quarterly Revenue Growth 0.323 | Return On Assets (0.18) | Return On Equity (0.93) |
The market value of AnaptysBio is measured differently than its book value, which is the value of AnaptysBio that is recorded on the company's balance sheet. Investors also form their own opinion of AnaptysBio's value that differs from its market value or its book value, called intrinsic value, which is AnaptysBio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AnaptysBio's market value can be influenced by many factors that don't directly affect AnaptysBio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AnaptysBio's value and its price as these two are different measures arrived at by different means. Investors typically determine if AnaptysBio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AnaptysBio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.